Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
about
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depressionBrain Structures Implicated in Inflammation-Associated Depression.Systemic inflammation enhances stimulant-induced striatal dopamine elevation.Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.Nonhuman primate models of depression: effects of early experience and stress.Depression in cancer patients: Pathogenesis, implications and treatment (Review).Levodopa reverses cytokine-induced reductions in striatal dopamine release.Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice.Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depressionKynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.Interferon-α acutely impairs whole-brain functional connectivity network architecture - A preliminary studyThe neuroimmune basis of fatigueInterleukin-1 as a mediator of fatigue in disease: a narrative review.Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.The role of inflammation in depression: from evolutionary imperative to modern treatment targetAssociation Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants.Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy.The Role of Resilience in the Clinical Management of Chronic Pain.Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms.The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.Cross Talk: The Microbiota and Neurodevelopmental Disorders.Do cytokines really sing the blues?Neuroinflammation: new vistas for neuropsychiatric research.Why is there motor deterioration in Parkinson's disease during systemic infections-a hypothetical view.Imaging the role of inflammation in mood and anxiety-related disorders.Anhedonia in depression: biological mechanisms and computational models.The relationship between interleukin-6 and functional connectivity in methamphetamine users.The association between fatigue and pain symptoms and decreased physical activity after cancer.Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice.The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure.
P2860
Q28830670-504DD972-952D-43F6-A0ED-DE8E0057DFFEQ31106139-6AAF8338-2619-44E4-9221-EA3BB3C5CB25Q33601884-6F3B4DE6-462C-4921-9A6A-08AFD8DB8FB3Q33654938-F52A1C52-78F3-468D-A8CA-C80BAEF3D768Q34556556-50DFF972-6513-4D81-B311-19FDB05932E2Q35167892-156973B5-21F2-4251-A83C-A7EE8454B098Q35178989-214CA9E0-7A81-4F76-991F-309C773AF13EQ36515078-306BC6D5-35D4-4533-BB86-208BFB2B29CCQ36889327-A19A1FA6-AE9A-4A3A-8787-4ECE22BE66DDQ36945317-01DAC4D5-3516-4D40-8921-BF27BAE6A5BEQ37357695-F5FDA19F-AD06-49B3-BA3C-C31D357C2C75Q37470201-8237ADB4-5F9F-4918-B541-6FDE882BBD4DQ37597282-39487F9F-8D46-4E52-A42C-038EB4072BEAQ38194251-2D8CD53A-D82C-4918-B4C2-579D5757F4C0Q38681725-77046FB5-467E-4C10-96EE-EF789639CBCDQ38683601-E39A210A-1E5F-42ED-9D93-4C0928A6D6BAQ38815010-A0A3BB7E-D6ED-41F9-AAAB-119F632F4F28Q38817933-06B71F77-F2A0-40DC-9D6B-1F58340B03A9Q38828405-9FDCC5B8-B332-47FD-A85F-A5E8B7BC8728Q38843536-F19AB4FD-424F-4D0C-A3BD-C967689726ECQ38844378-1DC20534-C78B-4113-9312-0FFFB08A2643Q38915253-875250D4-1548-47BA-AC1B-E290758980C1Q39867864-3311CF7E-6331-4066-8E95-B51126E9E6A7Q41665354-CA45A2FA-B664-4EFA-AA85-2472CC783EF8Q41886639-A70431B5-46A5-48B3-BBCD-1BEDE2A21C3FQ42248411-EE0A3EB4-78FD-48CF-A85C-3BD89398FC11Q42334435-ABD4D362-8076-41B3-8AFB-ECCC0B1F1886Q47305318-4D82A3EF-4497-4BCF-A491-1F3F5B759A6AQ50420903-96A0E486-32C3-4C48-909E-6ED060C0EE46Q52318363-A35E8373-AF62-4411-AE7C-E8B3DB25295EQ52575690-DCC78922-294E-4453-A3B2-E65618361768Q54237101-E0FF3879-3F49-4F05-B922-AEBA241ED6E1Q54940320-61728CDC-4259-40F5-9B02-CC5FCF0B077DQ55383738-8AEBE7CB-D031-40A9-9CA1-B2C016AB64CD
P2860
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@en
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@nl
type
label
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@en
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@nl
prefLabel
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@en
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@nl
P2093
P2860
P356
P1476
Chronic interferon-α decreases ...... behavior in nonhuman primates.
@en
P2093
Amanda A Freeman
Andrew H Miller
Carla R Hernandez
Daniel F Drake
David B Rye
Heather L Kimmel
Jennifer C Felger
Jiyoung Mun
Jonathon A Nye
Leonard L Howell
P2860
P2888
P304
P356
10.1038/NPP.2013.115
P407
P577
2013-05-09T00:00:00Z